Products

Levofloxacin

Levofloxacin 750 mg
 

Expand All
Collapse All

Active ingredient

Each film-coated tablet contains Levofloxacin 750 mg
 

Indications

  • To  reduce  the  development  of  drug-resistant  bacteria  and  maintain  the  effectiveness  of LEVOFLOXACIN  and other antibacterial drugs, LEVOFLOXACIN  should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
  • When  culture  and  susceptibility  information  are  available,  they  should  be  considered  in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
  • LEVOFLOXACIN are indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms.

Dosage and Administration

  • Route of administration: Oral.
  • The usual dose of LEVOFLOXACIN Tablets is 750 mg administered orally every 24 hours, as indicated by infection.

Contraindication

  • LEVOFLOXACIN  is contraindicated in persons with known hypersensitivity to levofloxacin, or other quinolone antibacterial.

Side effects

See the insert leaflet.

Drug Interaction

Pregnancy and Lactation

• Pregnancy:
No adequate and well-controlled studies in pregnant women.
LEVOFLOXACIN should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
• Lactation:
Based on data on other fluoroquinolones and very limited data on LEVOFLOXACIN, it can be presumed that levofloxacin will be excreted in human milk. Because of the potential for serious adverse reactions from LEVOFLOXACIN in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Warning and Precaution

  • Fluoroquinolones, including LEVOFLOXACIN, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants.
  • Fluoroquinolones, including LEVOFLOXACIN, may exacerbate muscle weakness in persons with myasthenia gravis. Avoid LEVOFLOXACIN in patients with a known history of myasthenia gravis.

Package and Storage

  • Carton box containing 1 blister of 5 film coated tablets and inner leaflet.
  • Store at temperature not exceeding 30⁰C in a dry place & protect from light. 

Mother Company

Manufactured by Marcyrl